<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00669539</url>
  </required_header>
  <id_info>
    <org_study_id>NEI-139</org_study_id>
    <secondary_id>2U10EY011751</secondary_id>
    <nct_id>NCT00669539</nct_id>
  </id_info>
  <brief_title>Observational Study of Optical Correction for Strabismic Amblyopia in Children 3 to &lt;7 Years Old</brief_title>
  <acronym>ATS13</acronym>
  <official_title>An Observational Study of Optical Correction for Strabismic Amblyopia in Children 3 to &lt;7 Years Old</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Jaeb Center for Health Research</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>National Eye Institute (NEI)</agency>
      <agency_class>NIH</agency_class>
    </collaborator>
  </sponsors>
  <source>Jaeb Center for Health Research</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study will evaluate the effectiveness of refractive correction alone for the treatment
      of previously untreated strabismic or combined-mechanism amblyopia in children 3 to &lt;7 years
      old with visual acuity of 20/40 to 20/400
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This study will evaluate the effectiveness of refractive correction alone for the treatment
      of previously untreated strabismic or combined-mechanism amblyopia in children 3 to &lt;7 years
      old with visual acuity of 20/40 to 20/400.

      A recently completed PEDIG study (ATS5) found that in 3 to &lt; 7-year-old children with
      previously untreated anisometropic amblyopia, refractive correction alone improved visual
      acuity by 2 or more lines in 77% of the patients and amblyopia resolved in at least one third
      of the patients. These results supported previous observations from retrospective and pilot
      studies as well as Stewart et al's prospective report on 18 children with anisometropic
      amblyopia whose visual acuity improved after treatment with spectacle correction only.

      Improvement in amblyopic eye visual acuity from treatment with optimum refractive correction
      in cases of anisometropic amblyopia is plausible because the refractive correction treats the
      underlying amblyogenic condition (i.e., uncorrected unequal refractive error) by providing
      retinal images of more similar clarity, size, and contrast. Elimination of the dissimilar
      retinal images, which may act as barriers to normal visual input, allows the amblyopic eye to
      receive appropriate visual stimulation. In contrast, visual acuity improvement with
      refractive correction alone in cases of amblyopia associated with strabismus is not expected
      to occur when the refractive correction does not completely eliminate the strabismus and
      restore fusion. In such cases, the underlying amblyogenic factor of a manifest ocular
      deviation remains; consequently, active cortical inhibition is presumably still present.
      Nonetheless, Stewart and colleagues recently reported finding gains in amblyopic eye visual
      acuity of children with strabismic and combined-mechanism amblyopia after a period of
      treatment with refractive correction alone. The PEDIG also observed this to occur in a
      subgroup of children with previously untreated strabismic and combined-mechanism amblyopia in
      a recent study. Amblyopic eye acuity improved by &gt;= 2 lines from spectacle-corrected baseline
      acuity in 9 (75%; 95% CI = 43% - 95%) of the 12 patients with strabismic amblyopia and in 9
      (69%, 95% CI = 39% - 91%) of the 13 patients with combined-mechanism amblyopia. Mean change
      from baseline to maximum improvement was 2.2 +- 1.8 and 2.6 +- 2.0 lines, respectively. These
      results are similar to those of Stewart and colleagues who reported visual acuity improvement
      averaging 3.0 lines in 16 children with strabismic amblyopia and 1.9 lines in 31 children
      with combined-mechanism amblyopia.

      Although our results support the suggestion of Stewart et al. that strabismic amblyopia can
      improve with spectacle correction alone, they are not conclusive because both studies had
      small numbers of patients. Also, our classification of strabismus was based on alignment
      without refractive correction. Thus, a larger controlled study is needed to confirm or refute
      these findings in patients with strabismic and combined-mechanism amblyopia.

      The ideal study design to answer the question of whether spectacles alone can significantly
      improve amblyopic eye visual acuity in strabismic children is a randomized trial with a
      control group who does not receive optical correction. However, most pediatric eye care
      providers would be reluctant to randomize esotropic children with hyperopic refractive error
      to a control group of no optical correction because of the likelihood of some children having
      accommodative esotropia, which would necessitate that hyperopic spectacles be prescribed. The
      number of esotropic amblyopes without an accommodative component is sufficiently few to make
      a randomized trial not feasible. Therefore, we have chosen to perform an observational study
      with a large number of children with pure strabismic and combined-mechanism amblyopia in
      order to evaluate the effect of refractive correction in this population of patients.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>May 2008</start_date>
  <completion_date type="Actual">December 2010</completion_date>
  <primary_completion_date type="Actual">May 2010</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Mean Amblyopic Eye Visual Acuity Improvement With Spectacles</measure>
    <time_frame>Enrollment to 18 Weeks</time_frame>
    <description>Acuity is measured in each eye using the Amblyopia Treatment Study (ATS) visual acuity testing protocol at baseline and at 18wks resulting in a Snellen acuity score that can range from 20/16 to 20/800. The score is converted to logMAR (log of min angle of resolution) for statistical analysis, and a difference between the scores is calculated. A positive difference indicates acuity was better at 18wks than at baseline; a negative difference indicates acuity was worse at 18wks than at baseline.</description>
  </primary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Actual">156</enrollment>
  <condition>Amblyopia</condition>
  <arm_group>
    <arm_group_label>Combined-Mechanism Amblyopia</arm_group_label>
  </arm_group>
  <arm_group>
    <arm_group_label>Strabismus-Only Amblyopia</arm_group_label>
  </arm_group>
  <eligibility>
    <study_pop>
      <textblock>
        Community Sample
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Age 3 to &lt;7 years old

          -  Able to perform visual acuity testing using the ATS single-surround HOTV protocol

          -  Amblyopia associated with strabismus (comitant or incomitant) with or without
             anisometropia

             *At least one of the following criteria must be met:

               -  Heterotropia at distance and/or near fixation on examination (without spectacles)

               -  History of strabismus surgery (or botulinum toxin extraocular muscle injection)

               -  Documented history of strabismus that is no longer present (and which in the
                  judgment of the investigator is the cause of amblyopia)

          -  Visual acuity measured in each eye according to the protocol procedures that meet the
             following criteria:

               -  Amblyopic eye 20/40 to 20/400 inclusive

               -  Sound eye &gt;=20/40

               -  Inter-eye acuity difference &gt;= 3 logMAR lines (i.e., amblyopic eye acuity at
                  least 3 logMAR lines worse than sound eye acuity)

          -  No previous spectacle correction

          -  Refractive error meeting at least 1 of the following criteria: &gt;= 1.00D of astigmatism
             in the amblyopic eye, &gt;= 1.00D spherical equivalent anisometropia, or &gt;= +2.00D
             spherical equivalent hyperopia in either eye.

          -  Investigator wishes to prescribe spectacles to correct refractive error

          -  Nystagmus per se does not exclude the patient if the above visual acuity criteria are
             met

          -  Ocular examination within 2 months prior to enrollment

          -  Cycloplegic refraction within 2 months prior to enrollment

          -  No myopia = -0.25D spherical equivalent)

          -  Parent understands protocol and is willing to accept treatment

          -  Parent has home phone (or access to phone) and is willing to be contacted by Jaeb
             Center staff

          -  Relocation outside of area of an active ATS site within next 6 months not anticipated

        Exclusion Criteria:

          -  Prior amblyopia treatment

          -  Current vision therapy or orthoptics

          -  Ocular cause for reduced visual acuity

          -  Prior intraocular or refractive surgery

          -  Strabismus surgery planned in the 9 weeks following the Baseline Visit
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>3 Years</minimum_age>
    <maximum_age>6 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Susan A. Cotter, O.D., M.S.</last_name>
    <role>Study Chair</role>
    <affiliation>Southern California College of Optometry</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Southern California College of Optometry</name>
      <address>
        <city>Fullerton</city>
        <state>California</state>
        <zip>92831-1699</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <results_reference>
    <citation>Writing Committee for the Pediatric Eye Disease Investigator Group, Cotter SA, Foster NC, Holmes JM, Melia BM, Wallace DK, Repka MX, Tamkins SM, Kraker RT, Beck RW, Hoover DL, Crouch ER 3rd, Miller AM, Morse CL, Suh DW. Optical treatment of strabismic and combined strabismic-anisometropic amblyopia. Ophthalmology. 2012 Jan;119(1):150-8. doi: 10.1016/j.ophtha.2011.06.043. Epub 2011 Sep 29.</citation>
    <PMID>21959371</PMID>
  </results_reference>
  <verification_date>July 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>April 28, 2008</study_first_submitted>
  <study_first_submitted_qc>April 28, 2008</study_first_submitted_qc>
  <study_first_posted type="Estimate">April 30, 2008</study_first_posted>
  <results_first_submitted>April 16, 2012</results_first_submitted>
  <results_first_submitted_qc>April 16, 2012</results_first_submitted_qc>
  <results_first_posted type="Estimate">May 21, 2012</results_first_posted>
  <last_update_submitted>July 7, 2016</last_update_submitted>
  <last_update_submitted_qc>July 7, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">July 13, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Amblyopia associated with strabismus</keyword>
  <keyword>Refractive error</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Amblyopia</mesh_term>
  </condition_browse>

  <clinical_results>

    <participant_flow>
      <group_list>
        <group group_id="P1">
          <title>Combined-Mechanism Amblyopia</title>
          <description>Chilren with strabismus and anisometropia who were prescribed refractive error correction with spectacles. The eye with worse visual acuity was labeled the amblyopic eye; the eye with better visual acuity was labeled the fellow eye. All analyses included only 1 observation per participant.</description>
        </group>
        <group group_id="P2">
          <title>Strabismus-Only Amblyopia</title>
          <description>Chilren with pure strabismus who were prescribed refractive error correction with spectacles. The eye with worse visual acuity was labeled the amblyopic eye; the eye with better visual acuity was labeled the fellow eye. All analyses included only 1 observation per participant.</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="94"/>
                <participants group_id="P2" count="52"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="86">Completed defined as completing 18 week primary outcome exam</participants>
                <participants group_id="P2" count="43">Completed defined as completing 18 week primary outcome exam</participants>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="8"/>
                <participants group_id="P2" count="9"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Combined-Mechanism Amblyopia</title>
          <description>Chilren with strabismus and anisometropia who were prescribed refractive error correction with spectacles. The eye with worse visual acuity was labeled the amblyopic eye; the eye with better visual acuity was labeled the fellow eye. All analyses included only 1 observation per participant.</description>
        </group>
        <group group_id="B2">
          <title>Strabismus-Only Amblyopia</title>
          <description>Chilren with pure strabismus who were prescribed refractive error correction with spectacles. The eye with worse visual acuity was labeled the amblyopic eye; the eye with better visual acuity was labeled the fellow eye. All analyses included only 1 observation per participant.</description>
        </group>
        <group group_id="B3">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="94"/>
            <count group_id="B2" value="52"/>
            <count group_id="B3" value="146"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <description>Age at enrollment in years</description>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="5.1" spread="1.1"/>
                    <measurement group_id="B2" value="4.7" spread="1.0"/>
                    <measurement group_id="B3" value="4.9" spread="1.1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Age, Customized</title>
          <description>Age at enrollment in years</description>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>3 to &lt;4 years</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="14"/>
                    <measurement group_id="B2" value="16"/>
                    <measurement group_id="B3" value="30"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>4 to &lt;5 years</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="35"/>
                    <measurement group_id="B2" value="16"/>
                    <measurement group_id="B3" value="51"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>5 to &lt;6 years</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="19"/>
                    <measurement group_id="B2" value="15"/>
                    <measurement group_id="B3" value="34"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>6 to &lt;7 years</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="26"/>
                    <measurement group_id="B2" value="5"/>
                    <measurement group_id="B3" value="31"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Gender</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Female</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="46"/>
                    <measurement group_id="B2" value="23"/>
                    <measurement group_id="B3" value="69"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Male</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="48"/>
                    <measurement group_id="B2" value="29"/>
                    <measurement group_id="B3" value="77"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Race/Ethnicity, Customized</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Asian</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="3"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Black/Aftican American</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="4"/>
                    <measurement group_id="B2" value="7"/>
                    <measurement group_id="B3" value="11"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Hispanic</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="4"/>
                    <measurement group_id="B2" value="7"/>
                    <measurement group_id="B3" value="11"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>White</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="82"/>
                    <measurement group_id="B2" value="37"/>
                    <measurement group_id="B3" value="119"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>More than one race</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="1"/>
                    <measurement group_id="B3" value="1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Unknown/not reported</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="1"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Distance Visual Acuity Amblyopic Eye</title>
          <description>Visual acuity was measured in the amblyopic eye using the Amblyopia Treatment Study (ATS) visual acuity testing protocol resulting in a Snellen acuity score that can range from 20/16 (best) to 20/800 (worst). Scores were converted to log of minimum angle of resolution (logMAR) equivalents for analyses (lower logMAR value is better than higher logMAR).</description>
          <units>logMAR</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0.64" spread="0.24"/>
                    <measurement group_id="B2" value="0.65" spread="0.26"/>
                    <measurement group_id="B3" value="0.64" spread="0.24"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Distance Visual Acuity in Fellow Eye</title>
          <description>Visual acuity was measured in the fellow eye using the Amblyopia Treatment Study (ATS) visual acuity testing protocol resulting in a Snellen acuity score that can range from 20/16 (best) to 20/800 (worst). Scores were converted to log of minimum angle of resolution (logMAR) equivalents for analyses (lower logMAR value is better than higher logMAR).</description>
          <units>logMAR</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0.09" spread="0.12"/>
                    <measurement group_id="B2" value="0.16" spread="0.11"/>
                    <measurement group_id="B3" value="0.12" spread="0.12"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Interocular Difference in Distance Visual Acuity</title>
          <description>The difference between eyes in logMAR visual acuity was calculated. Larger positive values of the difference indicate better visual acuity in the fellow eye, larger negative values indicate better visual acuity in the amblyopic eye, and small values indicate similar visual acuities between the eyes.</description>
          <units>logMAR lines</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="5.4" spread="2.4"/>
                    <measurement group_id="B2" value="4.9" spread="2.2"/>
                    <measurement group_id="B3" value="5.2" spread="2.3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Spherical Equivalent Refractive Error in Amblyopic Eye</title>
          <description>Spherical equivalent in diopters defined from cycloplegic refraction as sphere plus half the cylinder value in the amblyopic eye. Larger values indicate more refractive error; larger spherical equivalent values are worse than smaller values.</description>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>0 to &lt;+1.00 diopters (better)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="1"/>
                    <measurement group_id="B2" value="1"/>
                    <measurement group_id="B3" value="2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>+1.00 to &lt;+2.00 diopters</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="8"/>
                    <measurement group_id="B2" value="3"/>
                    <measurement group_id="B3" value="11"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>+2.00 to &lt;+3.00 diopters</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="5"/>
                    <measurement group_id="B2" value="17"/>
                    <measurement group_id="B3" value="22"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>+3.00 to &lt;+4.00 diopters</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="17"/>
                    <measurement group_id="B2" value="10"/>
                    <measurement group_id="B3" value="27"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>&gt;=+4.00 diopters (worse)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="63"/>
                    <measurement group_id="B2" value="21"/>
                    <measurement group_id="B3" value="84"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Spherical Equivalent Refractive Error in Amblyopic Eye</title>
          <description>Spherical equivalent in diopters defined from cycloplegic refraction as sphere plus half the cylinder value in the amblyoic eye. Larger values indicate more refractive error; larger spherical equivalent values are worse than smaller values.</description>
          <units>diopters</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="4.65" spread="1.79"/>
                    <measurement group_id="B2" value="3.69" spread="1.74"/>
                    <measurement group_id="B3" value="4.31" spread="1.83"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Spherical Equivalent Refractive Error in Fellow Eye</title>
          <description>Spherical equivalent in diopters defined from cycloplegic refraction as sphere plus half the cylinder value in the fellow eye. Larger values indicate more refractive error; larger spherical equivalent values are worse than smaller values.</description>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>0 to &lt;+1.00 diopters (better)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="11"/>
                    <measurement group_id="B2" value="1"/>
                    <measurement group_id="B3" value="12"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>+1.00 to &lt;+2.00 diopters</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="24"/>
                    <measurement group_id="B2" value="5"/>
                    <measurement group_id="B3" value="29"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>+2.00 to &lt;+3.00 diopters</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="32"/>
                    <measurement group_id="B2" value="17"/>
                    <measurement group_id="B3" value="49"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>+3.00 to &lt;+4.00 diopters</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="9"/>
                    <measurement group_id="B2" value="12"/>
                    <measurement group_id="B3" value="21"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>&gt;=+4.00 diopters (worse)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="18"/>
                    <measurement group_id="B2" value="17"/>
                    <measurement group_id="B3" value="35"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Spherical Equivalent Refractive Error in Fellow Eye</title>
          <description>Spherical equivalent in diopters defined from cycloplegic refraction as sphere plus half the cylinder value in the fellow eye. Larger values indicate more refractive error; larger spherical equivalent values are worse than smaller values.</description>
          <units>diopters</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="2.61" spread="1.60"/>
                    <measurement group_id="B2" value="3.44" spread="1.62"/>
                    <measurement group_id="B3" value="2.90" spread="1.65"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Ocular Alignment</title>
          <description>Minimum ocular alignment in prism diopters at distance or near defined from the simultaneous prism and cover test. Lower values of ocular alignment are better than higher values.</description>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>0 prism diopters (better)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="23"/>
                    <measurement group_id="B2" value="14"/>
                    <measurement group_id="B3" value="37"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>1-8 prism diopters</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="48"/>
                    <measurement group_id="B2" value="15"/>
                    <measurement group_id="B3" value="63"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>&gt;8 prism diopters (worse)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="23"/>
                    <measurement group_id="B2" value="23"/>
                    <measurement group_id="B3" value="46"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Ocular Alignment</title>
          <description>Minimum ocular alignment in prism diopters at distance or near defined from the simultaneous prism and cover test. Lower values of ocular alignment are better than higher values.</description>
          <units>prism diopters</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="5.7" spread="7.0"/>
                    <measurement group_id="B2" value="11.1" spread="14.5"/>
                    <measurement group_id="B3" value="7.6" spread="10.6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Mean Amblyopic Eye Visual Acuity Improvement With Spectacles</title>
        <description>Acuity is measured in each eye using the Amblyopia Treatment Study (ATS) visual acuity testing protocol at baseline and at 18wks resulting in a Snellen acuity score that can range from 20/16 to 20/800. The score is converted to logMAR (log of min angle of resolution) for statistical analysis, and a difference between the scores is calculated. A positive difference indicates acuity was better at 18wks than at baseline; a negative difference indicates acuity was worse at 18wks than at baseline.</description>
        <time_frame>Enrollment to 18 Weeks</time_frame>
        <population>Primary analysis includes only patients who completed the 18 week exam. No imputation was done if missed exam; analysis followed the intent to treat principle.</population>
        <group_list>
          <group group_id="O1">
            <title>Combined-Mechanism Amblyopia</title>
            <description>Chilren with strabismus and anisometropia who were prescribed refractive error correction with spectacles. The eye with worse visual acuity was labeled the amblyopic eye; the eye with better visual acuity was labeled the fellow eye. All analyses included only 1 observation per participant.</description>
          </group>
          <group group_id="O2">
            <title>Strabismus-Only Amblyopia</title>
            <description>Chilren with pure strabismus who were prescribed refractive error correction with spectacles. The eye with worse visual acuity was labeled the amblyopic eye; the eye with better visual acuity was labeled the fellow eye. All analyses included only 1 observation per participant.</description>
          </group>
        </group_list>
        <measure>
          <title>Mean Amblyopic Eye Visual Acuity Improvement With Spectacles</title>
          <description>Acuity is measured in each eye using the Amblyopia Treatment Study (ATS) visual acuity testing protocol at baseline and at 18wks resulting in a Snellen acuity score that can range from 20/16 to 20/800. The score is converted to logMAR (log of min angle of resolution) for statistical analysis, and a difference between the scores is calculated. A positive difference indicates acuity was better at 18wks than at baseline; a negative difference indicates acuity was worse at 18wks than at baseline.</description>
          <population>Primary analysis includes only patients who completed the 18 week exam. No imputation was done if missed exam; analysis followed the intent to treat principle.</population>
          <units>logMAR units</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="86"/>
                <count group_id="O2" value="43"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2.3" spread="1.8"/>
                    <measurement group_id="O2" value="3.2" spread="1.9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <group_list>
        <group group_id="E1">
          <title>Combined-Mechanism Amblyopia</title>
          <description>Chilren with strabismus and anisometropia who were prescribed refractive error correction with spectacles. The eye with worse visual acuity was labeled the amblyopic eye; the eye with better visual acuity was labeled the fellow eye. All analyses included only 1 observation per participant.</description>
        </group>
        <group group_id="E2">
          <title>Strabismus-Only Amblyopia</title>
          <description>Chilren with pure strabismus who were prescribed refractive error correction with spectacles. The eye with worse visual acuity was labeled the amblyopic eye; the eye with better visual acuity was labeled the fellow eye. All analyses included only 1 observation per participant.</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="94"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="52"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>5</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="94"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="52"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Raymond Kraker, MSPH</name_or_title>
      <organization>Jaeb Center for Health Research</organization>
      <phone>813-875-8690</phone>
      <email>pedig@jaeb.org</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

